Literature DB >> 17244790

Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment.

Li Tian1, Huan Shen, Qun Lu, Robert J Norman, Jim Wang.   

Abstract

OBJECTIVE: This study aims to examine the impact of insulin resistance (IR) on the risk of spontaneous abortion in patients who received infertility treatment. PATIENTS AND METHODS: This is a cohort study of 107 patients who achieved their first pregnancy after infertility treatment in a tertiary medical center. A homeostasis model assessment of IR (HOMA-IR) was carried out. Patient demographic characteristics and pregnancy outcome were also recorded. Statistical comparison was made between patients with and without IR. Logistical regression analysis was used to assess the effect of IR and several other factors simultaneously on the risk of spontaneous abortion.
RESULTS: The incidence of spontaneous abortion was 17.8%. The association of IR with the risk of spontaneous abortion was significant after adjusting for other risk factors. The effect of overweight/obesity and polycystic ovarian syndrome was not statistically significant in the multivariate model. DISCUSSION AND
CONCLUSION: This study suggested that IR was an independent risk factor for spontaneous abortion. Because of the high prevalence of IR in obese or polycystic ovarian syndrome patients, the risk of spontaneous abortion in these patients can be raised. Patients with IR should be advised to improve their insulin sensitivity through lifestyle change or medical intervention before infertility treatment to reduce their risk of spontaneous abortion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244790     DOI: 10.1210/jc.2006-1123

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Assessing the role of endometrial alteration among obese patients undergoing assisted reproduction.

Authors:  Eric D Levens; Monica C Skarulis
Journal:  Fertil Steril       Date:  2007-05-25       Impact factor: 7.329

2.  Morbid obesity and pregnancy outcomes after single blastocyst transfer: a retrospective, North American study.

Authors:  Miguel Russo; Senem Ates; Talya Shaulov; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2017-02-11       Impact factor: 3.412

3.  Definition and Multiple Factors of Recurrent Spontaneous Abortion.

Authors:  Xiaolin La; Wenjuan Wang; Meng Zhang; Li Liang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Introduction of Female Reproductive Processes and Reproductive Diseases.

Authors:  Jiajia Zhang; Jiao Li; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Insulin Signaling Via Progesterone-Regulated Insulin Receptor Substrate 2 is Critical for Human Uterine Decidualization.

Authors:  Alison M Neff; Jie Yu; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

6.  Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.

Authors:  Linda Sundvall; Kirstine Kirkegaard; Hans Jakob Ingerslev; Ulla Breth Knudsen
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

7.  Serum leptin and insulin hormone level in recurrent pregnancy loss.

Authors:  Rayah S Baban; Noor M Ali; Hala A Al-Moayed
Journal:  Oman Med J       Date:  2010-07

Review 8.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 9.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

Review 10.  [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].

Authors:  Michael Feichtinger; Tina Stopp; Christian Göbl
Journal:  Wien Med Wochenschr       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.